Correlation between Efficacy and Cardiovascular Adverse Events in Patients with Advanced Solid Cancer Who Received VEGF Pathway Inhibitors: Hypertension within the First Eight Weeks Is Associated with Favorable Outcomes of Patients Treated with VEGF Pathway Inhibitors

Yuya Yoshida(Tohoku University), Chikashi Ishioka(Tohoku University), Keigo Komine(Tohoku University), Ken Saijo(Tohoku University), Masanobu Takahashi(Shibaura Institute of Technology), Noriko Takenaga(Tohoku University Hospital), Yoshifumi Kawamura(Tohoku University), Sho Umegaki(Tohoku University), Keiju Sasaki(Tohoku University), Sakura Taniguchi(Tohoku University), Hidekazu Shirota(Tohoku University), Hideharu Yamada(Tohoku University Hospital), Kota Ouchi(Tohoku University), Yuki Kasahara(Tohoku University), Hiroo Imai(Tohoku University)
Internal Medicine
June 12, 2024
Cited by 4


Related Papers